title: Decreased incidence of graft-versus-host disease in bone marrow transplantation recipients treated with a combination of cyclosporine and methotrexate.
authors: Department of Transplantation Surgery, Karolinska Institute, Huddinge Hospital, Stockholm, Sweden.
authors: J
authors: J
authors: Tollemar
authors: O
authors: O
authors: Ringdén
authors: B
authors: B
authors: Sundberg
authors: P
authors: P
authors: Bolme
authors: C
authors: C
authors: Brattström
authors: G
authors: G
authors: Gahrton
authors: L
authors: L
authors: Johansen
authors: B
authors: B
authors: Lönnqvist
mesh_terms: D003524:Cyclosporins / Q000008:administration & dosage / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D006085:Graft Survival; D006086:Graft vs Host Disease / Q000453:epidemiology / Q000517:prevention & control*; D006648:Histocompatibility; D006801:Humans; D008727:Methotrexate / Q000008:administration & dosage / Q000627:therapeutic use*; D011300:Preoperative Care; D013548:Sweden
chemical_list: D003524:Cyclosporins; D008727:Methotrexate